Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

PECAN tariffs for digital medical devices with therapeutic function released in France

On April 25, 2024, the Ministry of Labor, Health, and Solidarity published an Order in the Official Journal of the French Republic setting the tariffs for digital medical devices with therapeutic functions covered within the early digital support (PECAN) scheme. The tariffs for the manufacturer providing the digital medical device with the therapeutic function will include:

  • The initial lump sum of €435 billable once for the same patient, for the effective use of the device for up to 3 months;
  • A subsequent adjustable lump sum, following the initial one, prorated according to the billing period, based on a monthly package of €38.30.

The maximum amount of financial compensation, composed of the two aforementioned lump sums, is €780 per year per patient.

More details can be found in French here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.